fitful 发表于 2025-3-21 17:29:17

        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)影响因子<br>        http://impactfactor.cn/if/?ISSN=1080-7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)影响因子@(药理学与药学)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=1080A7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)总引论文<br>        http://impactfactor.cn/at/?ISSN=1080-7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)总引论文@(药理学与药学)学科排名<br>        http://impactfactor.cn/atr/?ISSN=1080A7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)影响因子<br>        http://impactfactor.cn/tc/?ISSN=1080-7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)总引频次@(药理学与药学)学科排名<br>        http://impactfactor.cn/tcr/?ISSN=1080A7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)即时影响因子<br>        http://impactfactor.cn/ii/?ISSN=1080-7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)即时影响因子@(药理学与药学)学科排名<br>        http://impactfactor.cn/iir/?ISSN=1080A7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(20 21 REV HIST)五年累积影响因子<br>        http://impactfactor.cn/5y/?ISSN=1080-7683<br><br>        SCIE(SCI)期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS(J OCUL PHARMACOL TH)五年累积影响因子@(药理学与药学)学科排名<br>        http://impactfactor.cn/5yr/?ISSN=1080A7683<br><br>       

TOM 发表于 2025-3-21 23:30:45

http://reply.papertrans.cn/2/185/18438/18438-2.png

无能力之人 发表于 2025-3-22 01:57:31

Submitted on: 17 August 2022.
Revised on: 21 October 2022.
Accepted on: 01 December 2022.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

最高点 发表于 2025-3-22 06:31:59

Submitted on: 23 March 1999.
Revised on: 08 July 1999.
Accepted on: 27 July 1999.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Adulate 发表于 2025-3-22 09:58:56

Submitted on: 14 March 2008.
Revised on: 15 May 2008.
Accepted on: 21 June 2008.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

PLE 发表于 2025-3-22 14:26:27

Submitted on: 23 March 2011.
Revised on: 10 July 2011.
Accepted on: 09 August 2011.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

shrill 发表于 2025-3-22 18:02:30

http://reply.papertrans.cn/2/185/18438/18438-7.png

财主 发表于 2025-3-23 00:12:39

Submitted on: 17 October 2002.
Revised on: 24 November 2002.
Accepted on: 20 December 2002.

___________________JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

SLAY 发表于 2025-3-23 02:26:37

http://reply.papertrans.cn/2/185/18438/18438-9.png

个阿姨勾引你 发表于 2025-3-23 06:10:49

http://reply.papertrans.cn/2/185/18438/18438-10.png
页: [1] 2 3 4
查看完整版本: SCIE期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:1.963 (J OCUL PHARMACOL TH) (1080-7683). (PHARMACOL